Among all the immune checkpoints tested, PD-1 and CD80 on circulating sEVs were proven to be critically associated with HNSCC by their high variable importance scores (Fig. 1c), in additional to sEV PD-L1 as demonstrated in our previous research17. The gene discussed is CD80; the disease is head and neck squamous cell carcinoma.